BioRem (BRM) Planet MicroCap Showcase: TORONTO 2025 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase: TORONTO 2025 summary
23 Oct, 2025Capital structure and share buyback
Outstanding shares reduced from 38 million to 16 million after repurchasing a 60% block from a Chinese state-owned investor at roughly $0.51 per share, improving future structure.
Business model and technology
Offers a full suite of air emissions abatement technologies, including biological, physical, and chemical solutions, serving as a one-stop shop for clients.
Focuses on critical infrastructure, with up to 75% of business in government-funded, recession-resistant projects.
Solutions are applied across diverse industries, excelling in complex, highly regulated environments.
Financial performance and growth
Achieved continuous organic growth, with year-to-date bookings over $40 million and a record backlog exceeding $70 million.
Growth is driven by new products and services, with a third of new bids from these offerings.
Service group expansion has generated nearly $10 million in sales this year, with recurring revenue now a strategic focus.
Latest events from BioRem
- Record revenue and earnings growth in 2025, with strong order backlog and improved profitability.BRM
Q4 202520 Apr 2026 - Q2 revenue up 70% year-over-year, net earnings positive, and order backlog hits record $57M.BRM
Q2 202419 Apr 2026 - Record revenue and earnings with strong backlog signal continued growth ahead.BRM
Q3 202419 Apr 2026 - Record $71 million order backlog and strong bookings signal robust growth ahead.BRM
Q3 202519 Apr 2026 - Q2 2025 revenue up 29% year-over-year, net earnings $745,000, order backlog at $61 million.BRM
Q2 202512 Sep 2025 - Record $68M backlog and strong cash position offset Q1 revenue dip from project delays.BRM
Q1 202516 Jun 2025 - Record revenue, earnings, and backlog set the stage for 2025 growth despite Q4 margin pressure.BRM
Q4 20246 Jun 2025